Table 1.
Use of INCA recommendations for CRC screening
|
|||||
---|---|---|---|---|---|
Yes
|
No
|
|
|||
N | % | N | % | P-valueb | |
Total of units | 209 | 36 | 375 | 64 | |
Unit characteristics | |||||
Country region | 0.80 | ||||
South | 39 | 36 | 70 | 64 | |
Southeast | 65 | 35 | 119 | 65 | |
Central-West | 21 | 41 | 30 | 59 | |
Northeast | 73 | 36 | 128 | 64 | |
North | 11 | 28 | 28 | 72 | |
Total population covered | 0.36 | ||||
≤5000 | 142 | 37 | 241 | 63 | |
5001–15,000 | 23 | 29 | 55 | 71 | |
>15,000 | 14 | 31 | 31 | 69 | |
Patients per month | 0.35 | ||||
≤500 | 81 | 38 | 131 | 62 | |
501–1000 | 47 | 33 | 95 | 67 | |
>1000 | 38 | 31 | 85 | 69 | |
Unit capacity for CRC screening | |||||
CRC screening outreach | <0.001 | ||||
Yes | 134 | 64 | 10 | 3 | |
No | 74 | 36 | 363 | 97 | |
FOBT use | <0.001 | ||||
Yes | 136 | 69 | 140 | 39 | |
No | 62 | 31 | 223 | 61 | |
Sigmoidoscopy use | <0.001 | ||||
Yes | 49 | 26 | 43 | 12 | |
No | 140 | 74 | 307 | 88 | |
Colonoscopy use | <0.001 | ||||
Yes | 75 | 38 | 70 | 20 | |
No | 122 | 62 | 287 | 80 |
CRC: colorectal cancer; INCA: Brazilian National Cancer Institute; FOBT: fecal occult blood test.
Only coordinators who self-reported knowledge of INCA cancer screening recommendations and use of recommendations in the unit for cancer screening in general (N = 596 / 1251) were asked about use of colorectal cancer screening recommendations. Over 50% of the data are missing.
P value comparing units where INCA recommendations for CRC screening are used to those where they are not.